By Industry Standard Research
ISR recently ran a survey to assess dynamics in the Phase 1 clinical development space. Over 80% of respondents believe Phase 1 studies are getting more complex. Respondents also shared the percentages of their companys’ Phase 1 studies that use various practices. Over half of Phase 1 studies are executed in multiple sites/centers while about one-third take place in multiple countries. Additional locations and geographies create more complexity for study managers to juggle. Forty percent of studies take place in hospitals or academic centers, which can lead to more bureaucracy to navigate.